Stocks
Health Care
olma
Olema Pharmaceuticals
NASDAQ: OLMA
+10.78 (+126.53%)
19.3
USD
At close at Nov 18, 21:44 UTC
Overview
Loading chart...
Key Stats
Market Cap
584.76M
Dividend Yield
0.00%
P/E Ratio
-3.90
EPS
-2.10
Revenue
-
Avg. Volume
971.17K
Recently from Cashu
No Cashu articles
Olema Pharmaceuticals currently has no Cashu-related articles
About
What does OLMA do?
Olema Pharmaceuticals, based in San Francisco, develops targeted therapies for women's cancers, notably its lead candidate OP-1250, currently in Phase I/II trials for metastatic ER-positive breast cancer. The company went public on November 19, 2020, and employs 75 staff.
Sector
💻 Health Care
IPO
CEO
Employees
102
Headquarters
California, USA
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.